COMMUNIQUÉS West-GlobeNewswire

Le personnel infirmier du Canada célèbre la Semaine nationale des infirmières et des infirmiers praticiens en lançant un projet visant à augmenter les soins dispensés par les IP afin de répondre aux besoins croissants

13/11/2017 - 14:00

OTTAWA, 13 nov. 2017 (GLOBE NEWSWIRE) -- Afin de célébrer la Semaine nationale des infirmières et des infirmiers praticiens (IP), qui se tiendra du 12 au 18 novembre, le personnel infirmier du Canada lance un projet de [...]

Canada’s nurses celebrate National Nurse Practitioner Week by launching a project to expand NP care to meet growing need

13/11/2017 - 14:00

OTTAWA, Nov. 13, 2017 (GLOBE NEWSWIRE) -- In celebration of National Nurse Practitioner (NP) Week taking place from November 12 to 18, Canada’s nurses are launching a retention and recruitment project aimed at [...]

Diffusion Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

13/11/2017 - 14:00

FDA Clears Phase 3 Protocol for Patient Enrollment in GBM Brain Cancer Trial “First Patient In” Expected this Year Company Charter Amendment Addresses Nasdaq Listing Issue Additions to Board and Management Strengthen [...]

CymaBay Therapeutics to Present at Three Investor Conferences

13/11/2017 - 14:00

NEWARK, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Iovance Biotherapeutics to Present at the Jefferies 2017 London Healthcare Conference

13/11/2017 - 14:00

SAN CARLOS, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]

CRISPR Therapeutics Announces Appointment of Michael Tomsicek as Chief Financial Officer

13/11/2017 - 14:00

ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]

Emerald Health Therapeutics Announces Positive Health Canada Review of its Licensed Producer Application for Pure Sunfarms Facility

13/11/2017 - 14:00

RICHMOND, British Columbia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (TSXV:EMH) (OTCQX:EMHTF) announced today that its licensed producer application for the Pure Sunfarms Delta 3 greenhouse [...]

Interpace Diagnostics Group Reports Third Quarter 2017 Financial Results, Business Progress and Recent Accomplishments

13/11/2017 - 14:00

Q3-2017 Net Revenues of Over $4 Million Growing 27% Over Prior Year Quarter Represents Fourth Straight Quarter of Sequential Revenue Growth Net Loss for the Quarter & Year to Date a 56% and 51% Improvement Over [...]

Novo Nordisk A/S - Share repurchase programme

13/11/2017 - 13:33

Bagsværd, Denmark, 13 November 2017 - On 1 November 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Reata Pharmaceuticals, Inc. Announces Third Quarter 2017 Financial and Operating Results

13/11/2017 - 13:30

IRVING, Texas, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (Reata or Company), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended [...]

ProMIS Neurosciences Announces Third Quarter 2017 Results

13/11/2017 - 13:30

TORONTO, Ontario and CAMBRIDGE, Massachusetts, Nov. 13, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc., a company focused on the discovery and development of precision treatments for neurodegenerative diseases, [...]

Actinium Pharmaceuticals to Host Webcast to Introduce New Clinical Initiative in Collaboration with Leading Hematologist Dr. Gail Roboz

13/11/2017 - 13:30

- Dr. Gail Roboz, Director of the Leukemia Program and Professor of Medicine at Weill Cornell Medical College and NewYork-Presbyterian will introduce the planned clinical initiative on the webcast - Webcast to be held [...]

Clearside Biomedical’s Phase 1/2 Open Label Clinical Trial of CLS-TA With and Without Eylea in Diabetic Macular Edema Presented at the American Academy of Ophthalmology 2017 Annual Meeting

13/11/2017 - 13:30

ALPHARETTA, Ga., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, [...]

Neuralstem Reports Third Quarter 2017 Fiscal Results and Provides Clinical and Business Update

13/11/2017 - 13:30

GERMANTOWN, Md., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (NASDAQ: CUR ), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, reported [...]

RedHill Biopharma Reports 2017 Third Quarter Financial Results

13/11/2017 - 13:30

RedHill maintains a debt-free balance sheet with $39.6 million in cash 1 at the end of the third quarter of 2017 In addition, an underwritten public offering of the Company’s American Depositary Shares (ADSs) is [...]

Society for Immunotherapy of Cancer (SITC) Recognizes Immunovaccine Researchers with Journal for ImmunoTherapy of Cancer (JITC) “Best Basic Science Paper Award”

13/11/2017 - 13:05

HALIFAX, Nova Scotia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that the Society for Immunotherapy of Cancer (SITC) has [...]

FDA Clears World’s First and Only Wire-Free Radar Breast Tumor Localization System for Long Term Implant Capabilities

13/11/2017 - 13:00

ALISO VIEJO, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Cianna Medical, Inc. has received FDA clearance of the SAVI SCOUT® reflector for long term implant. The SAVI SCOUT reflector is an integral part of the SCOUT system [...]

Leap Therapeutics Reports Third Quarter 2017 Financial Results and Announces First Patient Dosed with DKN-01 and KEYTRUDA® (pembrolizumab) in Esophagogastric Cancer Trial

13/11/2017 - 13:00

CAMBRIDGE, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported financial results for the third [...]

Melinta Therapeutics Reports First Patient Treated in Phase 2 Study of Topical Radezolid for Treatment of Acne

13/11/2017 - 13:00

NEW HAVEN, Conn., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics , Inc. (NASDAQ: MLNT ) a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]